title: [Vasorelaxational effects of total alkali Sophora alopecuroids on rabbit aorta in vitro].
abstract: OBJECTIVE
  To study the vasodilation effects of the Total alkali Sophora alopecuroids L (TASa) on rabbit thoracic aortic rings in vitro and the possible mechanisms.
  
  
  METHODS
  Rabbit aortic rings were isolated and precontracted with noradrenaline (NA) and then were divided into six groups including control group, TASa group, TASa + 1 x 10(-5) mol x L(-1) indomethacin (Indo), TASa + 1 x 10(-5) mol x L(-1) propranolol (Prop), TASa + 1 x 10(-10 mol x L(-1) N(omega)-nitro-L-arginine (L-NNA), TASa + removal of endothelium. The vasodilation effects of TASa were investigated. In addition, the thoracic aortic rings were pre-treated with TASa (40 mg x L(-1)) and then the thoracic aortic rings were treated with cumulative NA (110(-8)-110(-5) mol x L(-1)), KCl (6.3-100 mmol x L(-1)) or CaCl2 (110(-5)-110(-2) mol x L(-1)). The dose response curves of aortic rings were recorded.
  
  
  RESULTS
  TASa can relax isolated rabbit aorta and has an obvious concentration-dependent relaxation (r = 0.94, P < 0.01). The relaxant effect of TASa was no significant reducing by removal of endothelium and by treatment with L-NNA, Indo or Prop. In addition, TASa can decrease the dose response curves of aortic rings to NA, KCl or CaCl2.
  
  
  CONCLUSIONS
  The vasodilation effects of TASa are related to not only inhibition of intracellular calcium release, but also reduction to calcium flow to the interior of the cell with blockage of calcium channels.
authors.affiliation: Department of Physiology, North Sichuan Medical College, Nanchong 637007, China.
authors.forename: Tuanxiao
authors.initials: T
authors.lastname: Zhang
authors.forename: Caiqin
authors.initials: C
authors.lastname: Niu
authors.forename: Wenli
authors.initials: W
authors.lastname: Mai
authors.forename: Huae
authors.initials: H
authors.lastname: Jing
authors.forename: Hong
authors.initials: H
authors.lastname: Liu
mesh_terms: D000468:Alkalies / Q000494:pharmacology*; D000818:Animals; D001013:Aorta, Thoracic / Q000187:drug effects* / Q000502:physiology; D005260:Female; D066298:In Vitro Techniques; D008297:Male; D009131:Muscle, Smooth, Vascular / Q000187:drug effects / Q000502:physiology; D009200:Myocardial Contraction / Q000187:drug effects; D010936:Plant Extracts / Q000737:chemistry / Q000494:pharmacology*; D011817:Rabbits; D029909:Sophora / Q000737:chemistry*; D014665:Vasodilator Agents / Q000737:chemistry / Q000494:pharmacology*
chemical_list: D000468:Alkalies; D010936:Plant Extracts; D014665:Vasodilator Agents